Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	MAML1 ZNF462 CREBRF KMT2C NCOA6 IRF2BPL ZFHX3 REST SSBP4 BCL9 MITF	2.07e-06	1390	30	11	GO:0045944
GeneOntologyBiologicalProcess	myoblast differentiation	MAML1 ZFHX3 REST BCL9	4.34e-05	136	30	4	GO:0045445
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	CPEB3 CREBRF KLF3 IRF2BPL ZFHX3 MAGEL2 REST MITF	9.61e-05	1053	30	8	GO:0000122
GeneOntologyCellularComponent	MLL3/4 complex	KMT2C NCOA6	1.30e-04	12	30	2	GO:0044666
Domain	UBA-like	UBALD2 UBALD1	5.04e-03	64	31	2	IPR009060
Pathway	WP_KLEEFSTRA_SYNDROME	KMT2C NCOA6 MBD5	1.35e-05	29	23	3	M48076
Pubmed	Interaction network of human early embryonic transcription factors.	MAML1 ZNF462 KLF3 KMT2C NCOA6 ZFHX3 BCL9 PRRC2B MITF	2.24e-11	351	32	9	38297188
Pubmed	Human transcription factor protein interaction networks.	MAML1 ZNF462 KLF3 KMT2C NCOA6 IRF2BPL ZFHX3 SSBP4 BCL9 ANKHD1 PRRC2B MITF	2.33e-09	1429	32	12	35140242
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NCOA6 IRF2BPL MAGEL2 TSC22D2 BCL9 MITF	2.38e-06	430	32	6	35044719
Pubmed	Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors.	KMT2C NCOA6	2.46e-06	3	32	2	18372346
Pubmed	Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis.	KMT2C NCOA6	2.46e-06	3	32	2	21330447
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	MAML1 KMT2C NCOA6 BCL9 ANKHD1 PRRC2B	3.38e-06	457	32	6	32344865
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MAML1 KMT2C NCOA6 SSBP4 BCL9 MBD5 ANKHD1 PRRC2B	5.40e-06	1105	32	8	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MAML1 KMT2C NCOA6 SIK3 ANKHD1 NCAPH	7.80e-06	529	32	6	14621295
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ATXN2L KMT2C NCOA6 ANKHD1 NCAPH PRRC2B	9.62e-06	549	32	6	38280479
Pubmed	A global genomic transcriptional code associated with CNS-expressed genes.	CPEB3 ZNF462 ZFHX3 MMS22L MITF	1.02e-05	318	32	5	16919269
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	MAML1 ATXN2L BCL9 PRRC2B	1.15e-05	152	32	4	38360978
Pubmed	Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases.	KMT2C NCOA6	1.23e-05	6	32	2	17021013
Pubmed	A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4.	KMT2C NCOA6	1.72e-05	7	32	2	19433796
Pubmed	ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.	KMT2C NCOA6	1.72e-05	7	32	2	19556342
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	KMT2C IRF2BPL SIK3 MBD5 NCAPH PRRC2B	3.45e-05	689	32	6	36543142
Pubmed	Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes.	TYMP MITF	3.67e-05	10	32	2	7588749
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	ZNF462 KMT2C IRF2BPL ZFHX3	4.88e-05	220	32	4	35785414
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ZNF462 KMT2C NCOA6 SIK3	5.32e-05	225	32	4	12168954
Pubmed	Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.	KMT2C NCOA6	6.36e-05	13	32	2	17761849
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	KMT2C NCOA6	7.41e-05	14	32	2	12482968
Pubmed	The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex.	KMT2C NCOA6	8.55e-05	15	32	2	17925232
Pubmed	High-throughput screen for genes predominantly expressed in the ICM of mouse blastocysts by whole mount in situ hybridization.	KMT2C REST ANKHD1	8.96e-05	94	32	3	16325481
Pubmed	SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53.	KMT2C NCOA6	9.76e-05	16	32	2	23870121
Pubmed	H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.	KMT2C NCOA6	9.76e-05	16	32	2	24368734
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	MAML1 NCOA6 BCL9 PRRC2B	1.05e-04	268	32	4	33640491
Pubmed	MLL3 and MLL4 Methyltransferases Bind to the MAFA and MAFB Transcription Factors to Regulate Islet β-Cell Function.	KMT2C NCOA6	1.11e-04	17	32	2	26180087
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	ZNF462 CREBRF ZFHX3 REST MBD5	1.22e-04	536	32	5	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	ZNF462 CREBRF ZFHX3 REST MBD5	1.24e-04	538	32	5	10512203
Pubmed	PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.	KMT2C NCOA6	1.24e-04	18	32	2	17500065
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	KMT2C NCOA6	1.54e-04	20	32	2	29785026
Pubmed	Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis.	KMT2C NCOA6	1.54e-04	20	32	2	19047629
Pubmed	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	ZNF462 BCL9	1.70e-04	21	32	2	24025145
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	KMT2C NCOA6	1.87e-04	22	32	2	26886794
Pubmed	Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.	CPEB3 REST SNAP91	2.23e-04	128	32	3	30995482
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	MAML1 NCOA6 SIK3 BCL9 PRRC2B	2.73e-04	638	32	5	31182584
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	IRF2BPL SSBP4	3.51e-04	30	32	2	26593974
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZNF462 KLF3 KMT2C ZFHX3 REST	4.43e-04	709	32	5	22988430
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	MAML1 ATXN2L KMT2C NCOA6 BCL9 PRRC2B	4.49e-04	1103	32	6	34189442
Pubmed	Aurora kinase A regulates Survivin stability through targeting FBXL7 in gastric cancer drug resistance and prognosis.	ZFHX3 REST	5.65e-04	38	32	2	28218735
Pubmed	Rab11-FIP1 and Rab11-FIP5 Regulate pIgR/pIgA Transcytosis through TRIM21-Mediated Polyubiquitination.	KMT2C MYRFL	6.58e-04	41	32	2	34638806
Pubmed	Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.	MAML1 NCOA6	6.58e-04	41	32	2	8724849
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L NCOA6 IRF2BPL REST BCL9	6.59e-04	774	32	5	15302935
Pubmed	Impact of WIN site inhibitor on the WDR5 interactome.	ZNF462 KMT2C	7.23e-04	43	32	2	33472061
Pubmed	Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.	ZNF462 MBD5 PRRC2B MITF	8.30e-04	463	32	4	27503909
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	ZNF462 KMT2C REST NCAPH	8.70e-04	469	32	4	27634302
Pubmed	Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Factor Family Identifies Importin 5 as a Bone Morphogenic Protein Receptor SMAD-specific Importin.	KMT2C NCOA6	9.01e-04	48	32	2	27703004
Interaction	EGR2 interactions	MAML1 ZNF462 KMT2C NCOA6 ZFHX3 BCL9 PRRC2B MITF	2.02e-10	171	32	8	int:EGR2
Interaction	FEV interactions	MAML1 ZNF462 KMT2C NCOA6 ZFHX3 BCL9 PRRC2B	2.58e-08	203	32	7	int:FEV
Interaction	SOX2 interactions	MAML1 ZNF462 CEP170P1 ATXN2L KLF3 KMT2C NCOA6 ZFHX3 BCL9 TYMP ANKHD1 PRRC2B MITF	9.94e-08	1422	32	13	int:SOX2
Interaction	ERG interactions	MAML1 KMT2C NCOA6 BCL9 PRRC2B MITF	1.22e-06	223	32	6	int:ERG
Interaction	PAX6 interactions	ZNF462 KMT2C NCOA6 ZFHX3 BCL9 PRRC2B MITF	1.40e-06	366	32	7	int:PAX6
Interaction	PAX7 interactions	MAML1 KMT2C ZFHX3 SSBP4 BCL9	1.43e-06	124	32	5	int:PAX7
Interaction	PAX9 interactions	MAML1 KMT2C NCOA6 ZFHX3 BCL9	1.81e-06	130	32	5	int:PAX9
Interaction	CRX interactions	MAML1 ZNF462 KMT2C ZFHX3 BCL9 PRRC2B	2.60e-06	254	32	6	int:CRX
Interaction	SP7 interactions	MAML1 KMT2C NCOA6 BCL9 PRRC2B MITF	7.30e-06	304	32	6	int:SP7
Interaction	TLX1 interactions	MAML1 ZNF462 KMT2C ZFHX3 BCL9	7.76e-06	175	32	5	int:TLX1
Interaction	GSC interactions	ZNF462 KMT2C ZFHX3 BCL9	1.06e-05	87	32	4	int:GSC
Interaction	HNF1B interactions	MAML1 KMT2C ZFHX3 BCL9 PRRC2B	1.16e-05	190	32	5	int:HNF1B
Interaction	KLF5 interactions	MAML1 KMT2C NCOA6 BCL9 PRRC2B	1.31e-05	195	32	5	int:KLF5
Interaction	GATA2 interactions	KMT2C NCOA6 ZFHX3 BCL9 PRRC2B	1.45e-05	199	32	5	int:GATA2
Interaction	PAX8 interactions	MAML1 KMT2C BCL9 PRRC2B	2.78e-05	111	32	4	int:PAX8
Interaction	TBR1 interactions	MAML1 KMT2C ZFHX3 BCL9	2.99e-05	113	32	4	int:TBR1
Interaction	TBXT interactions	MAML1 KMT2C NCOA6 BCL9	3.31e-05	116	32	4	int:TBXT
Interaction	NUP35 interactions	MAML1 KMT2C NCOA6 BCL9 ANKHD1 PRRC2B	4.77e-05	424	32	6	int:NUP35
Interaction	NFIB interactions	MAML1 KLF3 KMT2C BCL9	7.29e-05	142	32	4	int:NFIB
Interaction	LHX8 interactions	KLF3 SSBP4 BCL9	8.07e-05	53	32	3	int:LHX8
Interaction	TLX3 interactions	MAML1 KMT2C NCOA6 ZFHX3 BCL9	8.87e-05	291	32	5	int:TLX3
Interaction	LHX6 interactions	KLF3 SSBP4 BCL9	1.06e-04	58	32	3	int:LHX6
Interaction	AR interactions	MAML1 ZNF462 KMT2C NCOA6 IRF2BPL ZFHX3 BCL9 PRRC2B	1.22e-04	992	32	8	int:AR
Interaction	FOS interactions	KMT2C NCOA6 BCL9 ANKHD1 MITF	1.23e-04	312	32	5	int:FOS
Interaction	EHMT2 interactions	ZNF462 KLF3 IRF2BPL REST PRRC2B	1.29e-04	315	32	5	int:EHMT2
Interaction	GCM1 interactions	KMT2C BCL9 PRRC2B	1.70e-04	68	32	3	int:GCM1
Interaction	ASCL2 interactions	KMT2C NCOA6	1.88e-04	13	32	2	int:ASCL2
Interaction	LHX2 interactions	KMT2C ZFHX3 SSBP4 BCL9	1.94e-04	183	32	4	int:LHX2
Interaction	FOXL1 interactions	KMT2C ZFHX3 BCL9 NCAPH	2.52e-04	196	32	4	int:FOXL1
Interaction	TLE3 interactions	MAML1 KLF3 ZFHX3 SSBP4 BCL9	2.93e-04	376	32	5	int:TLE3
Interaction	DPY30 interactions	KMT2C NCOA6 MBD5 PRRC2B	2.94e-04	204	32	4	int:DPY30
Interaction	SOX17 interactions	KMT2C NCOA6 BCL9	4.56e-04	95	32	3	int:SOX17
Interaction	SOX9 interactions	KMT2C NCOA6 BCL9	4.84e-04	97	32	3	int:SOX9
Interaction	DDX3X interactions	ATXN2L MAGEL2 REST MBD5 ANKHD1 PRRC2B	4.91e-04	651	32	6	int:DDX3X
Interaction	WWTR1 interactions	ATXN2L NCOA6 ANKHD1 NCAPH PRRC2B	4.97e-04	422	32	5	int:WWTR1
Interaction	EYA4 interactions	MAML1 ATXN2L BCL9 PRRC2B	5.69e-04	243	32	4	int:EYA4
Interaction	LHX1 interactions	KMT2C SSBP4 BCL9	5.77e-04	103	32	3	int:LHX1
Interaction	H2BC12L interactions	CEP170P1 REST	6.05e-04	23	32	2	int:H2BC12L
Interaction	UTY interactions	KMT2C NCOA6	6.05e-04	23	32	2	int:UTY
Interaction	SSBP2 interactions	SSBP4 BCL9 TYMP	6.11e-04	105	32	3	int:SSBP2
Interaction	TLE6 interactions	MAML1 SSBP4	7.16e-04	25	32	2	int:TLE6
Interaction	LDB1 interactions	ZFHX3 SSBP4 BCL9	7.96e-04	115	32	3	int:LDB1
Interaction	PYGO1 interactions	SSBP4 BCL9	9.00e-04	28	32	2	int:PYGO1
Interaction	RCOR1 interactions	KLF3 ZFHX3 REST ANKHD1 NCAPH	1.01e-03	494	32	5	int:RCOR1
Cytoband	11p15.5	C11orf21 CDHR5	3.09e-03	118	32	2	11p15.5
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF462 KLF3 ZFHX3	1.32e-02	718	13	3	28
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	ZNF462 KLF3 KMT2C NCOA6 ZFHX3 REST BCL9 ANKHD1	6.91e-08	467	32	8	M1347
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	ZNF462 KLF3 KMT2C NCOA6 ZFHX3 REST BCL9 ANKHD1	9.09e-08	484	32	8	MM999
Coexpression	GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN	ZFHX3 CHCHD10 SSBP4 NCAPH UBALD1	4.19e-06	200	32	5	M3931
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CPEB3 ZNF462 CREBRF IRF2BPL ZFHX3 SIK3 SNAP91 PRRC2B	4.17e-05	1106	32	8	M39071
Coexpression	GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	CREBRF KMT2C BCL9 PRRC2B	8.90e-05	194	32	4	M3321
Coexpression	GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN	CREBRF KLF3 SIK3 TSC22D2	9.07e-05	195	32	4	M7310
Coexpression	GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN	MAML1 CREBRF KLF3 UBALD2	1.00e-04	200	32	4	M5980
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	SIK3 TSC22D2 MBD5 MITF	1.16e-04	208	32	4	M39233
Coexpression	GUO_HEX_TARGETS_UP	ZFHX3 MAGEL2 REST	1.18e-04	78	32	3	M1436
Coexpression	GUO_HEX_TARGETS_UP	ZFHX3 MAGEL2 REST	1.27e-04	80	32	3	MM626
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	ZFHX3 TSC22D2 MITF	1.47e-04	84	32	3	M13008
Coexpression	SUZUKI_AMPLIFIED_IN_ORAL_CANCER	BCL9 MITF	1.94e-04	17	32	2	M15351
Coexpression	ZWANG_EGF_INTERVAL_DN	CPEB3 KLF3 IRF2BPL BCL9	1.95e-04	238	32	4	M2620
Coexpression	LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B	KMT2C SIK3 MITF	2.69e-04	103	32	3	M39240
Disease	Paroxysmal atrial fibrillation	ZNF462 IRF2BPL ZFHX3 MBD5 MYPN	6.95e-07	156	32	5	C0235480
Disease	familial atrial fibrillation	ZNF462 IRF2BPL ZFHX3 MBD5 MYPN	6.95e-07	156	32	5	C3468561
Disease	Persistent atrial fibrillation	ZNF462 IRF2BPL ZFHX3 MBD5 MYPN	6.95e-07	156	32	5	C2585653
Disease	Atrial Fibrillation	ZNF462 IRF2BPL ZFHX3 MBD5 MYPN	7.88e-07	160	32	5	C0004238
Disease	feeling nervous measurement	NCOA6 IRF2BPL MMS22L MBD5	2.38e-06	87	32	4	EFO_0009597
Disease	body fat percentage	ATXN2L KLF3 ZFHX3 MMS22L TSC22D2 PRRC2B	1.25e-05	488	32	6	EFO_0007800
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	ATXN2L KLF3 ZFHX3 MMS22L TSC22D2	4.26e-05	364	32	5	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	forced expiratory volume	ATXN2L NCOA6 REST BCL9 PRRC2B MYPN	1.79e-04	789	32	6	EFO_0004314
Disease	QT interval	ATXN2L ZFHX3 MBD5 PRRC2B MITF	2.56e-04	534	32	5	EFO_0004682
Disease	brain measurement, neuroimaging measurement	ZNF462 ATXN2L ZFHX3 TSC22D2 MITF	2.93e-04	550	32	5	EFO_0004346, EFO_0004464
Disease	vital capacity	ATXN2L NCOA6 ZFHX3 MMS22L SSBP4 UBALD1 MYPN	2.98e-04	1236	32	7	EFO_0004312
Disease	myeloid white cell count	KLF3 ZFHX3 REST SIK3 SSBP4 BCL9	4.51e-04	937	32	6	EFO_0007988
Disease	lung non-small cell carcinoma (is_implicated_in)	KMT2C ZFHX3 TYMP	4.59e-04	139	32	3	DOID:3908 (is_implicated_in)
Disease	caudate nucleus volume	ATXN2L ZFHX3	4.86e-04	30	32	2	EFO_0004830
Disease	triacylglycerol 54:3 measurement	SIK3 MYPN	5.20e-04	31	32	2	EFO_0010421
Disease	triacylglycerol 54:5 measurement	MMS22L SIK3	5.54e-04	32	32	2	EFO_0010423
Disease	neuroimaging measurement	ZNF462 ATXN2L KLF3 TSC22D2 SNAP91 MITF	9.00e-04	1069	32	6	EFO_0004346
Disease	monocyte percentage of leukocytes	CPEB3 MAML1 KLF3 SSBP4 MBD5	1.06e-03	731	32	5	EFO_0007989
Disease	sexual dimorphism measurement	ZNF462 ATXN2L NCOA6 ZFHX3 REST SIK3	1.07e-03	1106	32	6	EFO_0021796

Protein segments in the cluster

Peptide	Gene	Start	Entry
MPQPSVSGMDPPFGD	CREBRF	1	Q8IUR6
MPTMAPAGQPAPVSM	SNAP91	726	O60641
PMPPSMGTSTSHQPA	CDHR5	581	Q9HBB8
PASAPPMMQAAAAAG	ATXN2L	761	Q8WWM7
PNRPMAPMSSAAAVG	MAML1	886	Q92585
AQMDPPQMGPAPTEA	REST	606	Q13127
PFGVPLSMPPVMAAA	KLF3	116	P57682
PTPPPMACQKMANGF	KMT2C	3906	Q8NEZ4
APMTQPPASGAPMAQ	MAGEL2	296	Q9UJ55
APMAQPAAPPAQPMA	MAGEL2	306	Q9UJ55
MDMPSTAPSDFQPQP	MMS22L	751	Q6ZRQ5
APQNGPSPMAALMSV	IRF2BPL	616	Q9H1B7
AAPAMPPMHPLQSTS	MYRFL	91	Q96LU7
SSSMMAPGPNPELQP	NCOA6	191	Q14686
APPAPNGPDKMQMES	CPEB3	61	Q8NE35
PAPSGQPGLMAQMAT	CHCHD10	36	Q8WYQ3
PARSPNLPSMNNMPG	BCL9	1041	O00512
TAPSMPGHNPMRPPA	BCL9	1306	O00512
MPGQPTLMSNPAAAV	BCL9	1341	O00512
ALNNMGFPSAMLPSP	CEP170P1	211	Q96L14
NFMMPPVGPQATSSG	MBD5	471	Q9P267
PGAATGPQPMMAAAQ	TSC22D2	296	O75157
SNSPPPMSSAMIQPH	SIK3	746	Q9Y2K2
PMSMPFASNSEPAPL	ANKHD1	2091	Q8IWZ3
MGPPGPALPATMNNS	NCAPH	1	Q15003
APGSMMPPAAAQPSA	C11orf21	51	Q9P2W6
PVPGSSAPNSPMAML	MITF	171	O75030
PPNSLAGPGLPAMNM	SSBP4	221	Q9BWG4
PMPVASVAPSASMPG	PRRC2B	1906	Q5JSZ5
MMCTPSNTPATPPNF	UBALD2	61	Q8IYN6
GAPMSPKMSNMGSPP	ZNF462	1086	Q96JM2
MAALMTPGTGAPPAP	TYMP	1	P19971
MMCTPANTPATPPNF	UBALD1	61	Q8TB05
FQLDPAGPMAAMTPA	ZFHX3	891	Q15911
PPTNAMGLPRSAPSM	MYPN	841	Q86TC9